Aktualizacja opinii ekspertów Sekcji Krążenia Płucnego Polskiego Towarzystwa Kardiologicznego dotycząca badań przesiewowych w kierunku CTEPH u chorych po …

M Ciurzyński, M Kurzyna, G Kopeć… - Polish Heart …, 2022 - journals.viamedica.pl
Przewlekłe zakrzepowo-zatorowe nadciśnienie płucne (CTEPH) jest rzadkim powikłaniem,
występującym u ok. 4% pacjentów po przebytej ostrej zatorowości płucnej (OZP). Sugeruje …

[HTML][HTML] Plasma Troponins Identify Patients with Very Low-Risk Acute Pulmonary Embolism

B Karolak, M Ciurzyński, M Skowrońska… - Journal of Clinical …, 2023 - mdpi.com
Introduction: Although in the non-vitamin K oral anticoagulants (NOAC) era majority of low-
risk acute pulmonary embolism (APE) patients can be treated at home, identifying those at …

Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease

F Crea - European Heart Journal, 2022 - academic.oup.com
This Focus Issue on ischaemic heart disease contains the Fast Track Clinical Research
article entitled 'Duration of antiplatelet therapy after complex percutaneous coronary …

Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6-and 12-months SARS-CoV-2 infection

P Poyatos Dorado, N Luque… - Infection, 2024, vol …, 2024 - dugi-doc.udg.edu
SARS-CoV-2 infection causes severe endothelial damage, an essential step for
cardiovascular complications. Endothelial-colony forming cells (ECFCs) act as a biomarker …

[PDF][PDF] Pulmonary thromboembolic disease associated with COVID-19 infection: a comparison between geriatric and non-geriatric populations

TL Tan, NE Illa, SY Ting, PL Hwong, NK Makhtar… - Med J Malaysia, 2023 - e-mjm.org
ABSTRACT Introduction: The magnitude of Coronavirus Disease 2019 (COVID-19) infection
among the elderly population is expected to rise. Our study compares the clinical and …

[HTML][HTML] Pulmonary embolism in patients with severe COVID-19 treated with systemic low-dose thrombolytic therapy: A case series

IGNM Aribawa, C Ryalino, AP Pradhana… - … Journal of Critical …, 2022 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19) has been associated with respiratory failure
and high mortality. Hypercoagulability and thromboembolic complications have been found …

Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment

F Crea - European Heart Journal, 2021 - academic.oup.com
This Issue opens with a joint Special Article entitled 'Clinician wellbeing—addressing global
needs for improvements in the health care field: a joint opinion from the American College of …

Suction‐based catheter retrieval of right ventricular clot‐in‐transit

LT Li, M Alexis, SR Wilson, PJ Yu - Catheterization and …, 2023 - Wiley Online Library
Right ventricular clot‐in‐transit (CIT) is a rare finding in venous thromboembolic disease and
carries a high mortality rate. Its optimal treatments have yet to be established in the literature …

Anticoagulation failure in pulmonary thromboembolism in COVID-19 pneumonia despite prolonged anticoagulation: A case series

P Sapkota, A Tamang, S Bhandari… - Annals of Medicine …, 2022 - journals.lww.com
Method: We report a case series of seven cases aged 40–70 who were presented in
Dhulikhel Hospital with COVID-19 symptoms in different stages. The case details were …

Myocardial Infarction, Deep Venous Thrombosis and Pulmonary Embolism in COVID-19 Hospitalizations: Stats from the Nationwide Inpatient Sample 2020

E Endurance, O Ovie, G Alugba… - … and Angiology: An …, 2023 - ebooks.manu2sent.com
Background: The outcomes of SARS-CoV-2 (COVID) hospitalizations and their association
with myocardial injury and thrombosis were studied. We aimed to provide further insights …